Ross Upton appears in Brel Digital’s verified company_founders attribution for Ultromics based in United Kingdom in the Healthcare sector. This profile records that founder relationship using sources already on file for the company. Personal biography details that are not evidenced in those sources are omitted.
Company context (from the verified Ultromics profile): Oxford echocardiography AI company with FDA-cleared EchoGo platform for heart failure and cardiac amyloidosis detection from standard ultrasound
Why the company matters (verified company field): Ultromics attacks one of cardiology's costliest blind spots — up to 64% of HFpEF cases undiagnosed per its July 2025 Series C release — by extracting disease signals from routine echocardiograms already performed millions of times annually, with Medicare reimbursement making hospital ROI calculable.
Official company website on file: https://ultromics.com. Readers should consult that site and the Sources section for primary evidence.
Brel Digital does not invent prior roles, education, funding history, or awards for founder profiles. Where additional verified public leadership pages become available, this profile should be deepened in a subsequent editorial review.